Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN drug discovery
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
UMSL announces 24 faculty promotions ahead of 2025-26 academic year
Nine faculty members were granted tenure and four were awarded the rank of full professor. Of the 11 non-tenure track faculty members receiving promotions, one received the rank of full teaching professor.
MORE IN drug discovery
LATEST NEWS
- UMSL announces 24 faculty promotions ahead of 2025-26 academic year
- UMSL Tritons weekly rewind
- UMSL alum Megan Rapp helps preserve Mark Twain’s legacy in Hannibal and beyond
- Optometry graduate Alex Fenson launching career in vision therapy
- 3 questions with John Ampomah, master’s student in criminology and criminal justice
- UMSL College of Optometry launches partnership with Kansas City University Biomedical Sciences Program
- Returning to her roots: Lúcia Lohmann takes over leadership of Missouri Botanical Garden
- AACSB renews College of Business Administration’s dual accreditation for all business and accounting programs
- Upcoming BSN graduate Miranda Martin lands position as operating room nurse at SSM Health DePaul Hospital
- Succeed+ student Jaylin Brown meets with legislators in Washington to advocate for postsecondary education
